Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPBI
501
DELISTED
Pacific Premier Bancorp
PPBI
| $909K | ﹤0.01% |
+48,245
| New | +$1.28M |
|
502
Euronet Worldwide
EEFT
$2.73B
| $902K | ﹤0.01% |
+10,517
| New | +$1.39M |
|
503
Amkor Technology
AMKR
$13.5B
| $890K | ﹤0.01% |
114,312
+26,673
| +30% | +$290K |
|
504
NovoCure
NVCR
$1.83B
| $889K | ﹤0.01% |
13,201
-179
| -1% | -$14.1K |
|
505
Wabash National
WNC
$512M
| $866K | ﹤0.01% |
119,992
+82,230
| +218% | +$921K |
|
506
Progressive
PGR
$125B
| $849K | ﹤0.01% |
+11,493
| New | +$886K |
|
507
First Industrial Realty Trust
FR
$8.4B
| $845K | ﹤0.01% |
+25,440
| New | +$1.01M |
|
|
PRFT
508
DELISTED
Perficient Inc
PRFT
| $842K | ﹤0.01% |
+31,097
| New | +$1.36M |
|
|
EB
509
DELISTED
Eventbrite
EB
| $840K | ﹤0.01% |
115,023
-88,077
| -43% | -$1.49M |
|
510
NeoGenomics
NEO
$2B
| $838K | ﹤0.01% |
+30,347
| New | +$909K |
|
|
TMHC
511
DELISTED
Taylor Morrison
TMHC
| $837K | ﹤0.01% |
76,048
+37,257
| +96% | +$801K |
|
512
AMN Healthcare
AMN
$1.19B
| $771K | ﹤0.01% |
+13,343
| New | +$913K |
|
513
Federated Hermes
FHI
$4.72B
| $768K | ﹤0.01% |
40,341
+6,988
| +21% | +$207K |
|
|
LTC
514
LTC Properties
LTC
$2.02B
| $767K | ﹤0.01% |
24,826
+142
| +0.6% | +$6.07K |
|
515
Hilltop Holdings
HTH
$2.25B
| $759K | ﹤0.01% |
50,194
+1,626
| +3% | +$34.4K |
|
|
VRE
516
DELISTED
Veris Residential
VRE
| $737K | ﹤0.01% |
48,423
+21,209
| +78% | +$434K |
|
517
Medpace
MEDP
$16.3B
| $728K | ﹤0.01% |
9,916
+235
| +2% | +$20.4K |
|
|
NS
518
DELISTED
NuStar Energy L.P.
NS
| $723K | ﹤0.01% |
+84,197
| New | +$1.83M |
|
|
MODN
519
DELISTED
MODEL N, INC.
MODN
| $721K | ﹤0.01% |
+32,443
| New | +$948K |
|
520
Itron
ITRI
$4.5B
| $718K | ﹤0.01% |
+12,868
| New | +$978K |
|
|
TECD
521
DELISTED
Tech Data Corp
TECD
| $706K | ﹤0.01% |
5,396
+949
| +21% | +$132K |
|
522
UFP Industries
UFPI
$5.19B
| $684K | ﹤0.01% |
18,402
-10,716
| -37% | -$492K |
|
|
KW
523
DELISTED
Kennedy-Wilson Holdings
KW
| $672K | ﹤0.01% |
50,058
+9,016
| +22% | +$180K |
|
524
Bio-Rad Laboratories Class A
BIO
$9.16B
| $671K | ﹤0.01% |
+1,915
| New | +$704K |
|
525
CBIZ
CBZ
$2.96B
| $670K | ﹤0.01% |
32,007
+352
| +1% | +$8.96K |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.